Home › Funds › Newport Trust Company, LLC › ELV

Newport Trust Company, LLC position in ELV

ELEVANCE HEALTH INC FORMERLY · Health Care

Newport Trust Company, LLC reported holding 927,194 shares of ELV (ELEVANCE HEALTH INC FORMERLY) in its Q3 2026 13F filing — a position valued at US$360.5M, representing 0.97% of its reported portfolio and ranking #20 among its reported holdings. Newport Trust Company, LLC has disclosed ELV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)927.19K sh
Reported value held$360.51M
Portfolio Weight0.97%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Newport Trust Company, LLC's ELV position evolved

Newport Trust Company, LLC first disclosed a stake in ELV in Q3 2023 at 1,241,638 shares (US$540.6M). The position peaked in Q2 2024 at 1,145,768 shares, worth US$620.8M. Across 13 filings, Newport Trust Company, LLC increased the stake 0 time(s), trimmed it 12 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 927,194 shares valued at US$360.5M — a reduction of -27,721 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 1.24M $540.63M New
Q4 2023 1.21M $570.83M Reduce
Q1 2024 1.18M $611.45M Reduce
Q2 2024 1.15M $620.85M Reduce
Q3 2024 1.13M $586.77M Reduce
Q4 2024 1.11M $408.05M Reduce
Q1 2025 1.07M $464.13M Reduce
Q2 2025 1.05M $406.87M Reduce
Q3 2025 1.02M $330.88M Reduce
Q4 2025 1.01M $352.31M Reduce
Q1 2026 985.19K $288.41M Reduce
Q2 2026 954.91K $369.29M Reduce
Q3 2026 927.19K $360.51M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ELV and 13F data

ELV (ELEVANCE HEALTH INC FORMERLY) is a Health Care company. 23 other funds we track also report a position in ELV — the largest reported positions include Wellington Management Group (US$3.56B), WELLINGTON MANAGEMENT GROUP LLP (US$3.56B), Sanders Capital, LLC (US$2.27B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ELV

All ELV fund holders →

FAQ

How long has Newport Trust Company, LLC held ELV?

Newport Trust Company, LLC has disclosed ELV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Newport Trust Company, LLC's current position in ELV?

As of Q3 2026, Newport Trust Company, LLC holds 927.19K shares of ELV (ELEVANCE HEALTH INC FORMERLY), valued at $360.51M, representing 0.97% of its reported portfolio and ranking #20.

Has Newport Trust Company, LLC been buying or selling ELV?

In the latest 13F filing (Q3 2026), Newport Trust Company, LLC reduced its position in ELV. The position peaked in Q2 2024 at 1.15M shares.

Which other funds hold ELV?

Other major institutional holders of ELV include Wellington Management Group, WELLINGTON MANAGEMENT GROUP LLP, Sanders Capital, LLC, among 23 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.